Bloomberg Law: Privacy & Data Security brings you single-source access to the expertise of Bloomberg Law’s privacy and data security editorial team, contributing practitioners,...
Aetna Inc. settled Jan. 23 with the New York attorney general over claims the insurance provider sent letters that exposed, through a transparent address window, the HIV status of 2,460 state residents.
The insurance provider will pay $1.15 million in civil penalties under the settlement agreement. Aetna didn’t admit fault under the agreement, but agreed to update privacy protections for personal health information and hire outside consultants to monitor compliance with the settlement.
The agreement demonstrates that companies handling sensitive health information not only need to employ electronic data security safeguards, but protect sensitive personal information from public view or face the risk of regulatory enforcement.
“Health insurance companies handle personal health information on a daily basis and have a fundamental responsibility to be vigilant in protecting their members,” N.Y. Attorney General Eric Schneiderman (D) said in a Jan. 23 statement. The office alleged violations of New York state health privacy laws and the federal Health Insurance Portability and Accountability Act (HIPAA), which prohibit the disclosure of sensitive health information.
The settlement stems from Schneiderman’s July 2017 investigation of Aetna in which his office found that Aetna sent letters with a “large transparent glassine window that could easily reveal the HIV status” of health plan members, according to the settlement announcement. The way the letters were put into the envelopes allowed people to see “individuals’ names, addresses, and claim numbers, as well as the first several lines of the letter containing instructions related to HIV medications,” according to the announcement.
The investigation exposed another alleged Aetna health data breach. The insurance provider in September 2017 sent 163 letters to state residents containing health research study materials. Aetna used envelopes that clearly showed the logo of the trial study, “which could have been interpreted as indicating that the recipient member” had a health condition, the settlement announcement said.
To contact the reporter on this story: Daniel R. Stoller in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Donald Aplin at email@example.com
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)